Stronger Sell Today ACOR ranks #4875 as SELL CANDIDATE. Weaker Sell
Today ACOR ranks #4875 as SELL CANDIDATE.

ACOR stock Acorda Therapeutics

ACOR stock
Acorda Therapeutics

18 January 2019
Change -3.73%
Chart period: 2018-10-19 - 2019-01-18
VOLUME
Buy
TREND
Sell

MV LONG
Sell

MV SHORT
Sell

PIVOT
Sell

MACD
Buy
Request Prediction
Predict

Acorda Therapeutics Stock Analysis

Technical stock analysis for 18 January 2019

Sell candidate since 2019-01-18
Shorts n/a
Cash n/a
Loans 335.1 mill
Beta 1.67
ROA -11.12

Acorda Therapeutics fell by -3.73% in the last day from $16.89 to $16.26 The price has been going up and down for this period, and there has been a -2.75% loss for the last 2 weeks. Volume has increased in the last day by 32 196 shares, but on falling prices. This may be an early warning and the risk will be increased slightly for the next couple of days. In total, 780 247 shares bought and sold for approximately $12.69 million.

Close price at the end of the last trading day (Friday, 18th Jan 2019) of the ACOR stock was $16.26. This is 3.73% less than the trading day before Thursday, 17th Jan 2019.

During day the stock fluctuated 6.41% from a day low at $16.06 to a day high of $17.09.

30 day high of the ACOR stock price was $17.57 and low was $12.86.
90 day high was $21.63 and low was $12.86.
52 week high for the Acorda Therapeutics - $36.35 and low - $12.86.

Trend

Acorda Therapeutics lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -17.81% during the next 3 months and, with 90% probability hold a price between $9.65 and $15.39 at the end of this period.

Click here for today's Top 5 Trending Companies

Signals

There are few to none technical positive signals at the moment. Acorda Therapeutics holds sales signals from both short- and long-term moving averages. On corrections up there will be some resistance from the lines at $16.78 and $16.75. A break-up above any of these levels will issue buy signals. A sales signal was issued from a pivot top point on Thursday January 10, 2019, which indicates further falls until a new bottom pivot has been found. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

RSI14 is 60 and the stock is currently not being overbought or oversold

Access full RSI 14 and RSI 21 lists

Support & Resistance

Acorda Therapeutics finds support from accumulated volume at $16.18.

Support: $16.18 Price: $16.26 Resistance: $16.98

Risk

This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $1.03 between high and low, or 6.41%. For the last week, the stock has had a daily average volatility of 4.30%.

Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.

Overall risk:

Very Low Low Medium High Very High

Evaluation

Acorda Therapeutics holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our recommendation for this stock since last evaluation from a Buy Candidate to a Sell Candidate.

Stronger Sell Today ACOR ranks #4875 as SELL CANDIDATE. Weaker Sell
Today ACOR ranks #4875 as SELL CANDIDATE.